ALIGNMT AI emerges from stealth with $6.5M in funding to tackle healthcare AI compliance and risk monitoring

AI is moving fast in healthcare, but the risks are moving just as quickly. From biased algorithms that could affect patient outcomes to billing errors that expose hospitals to fraud, compliance has become one of the most pressing issues for health systems rolling out machine learning tools. That’s the gap that healthcare AI governance startup ALIGNMT AI wants to close, and it just raised a few million to do it.

Today, ALIGNMT AI announced it has raised $6.5 million in seed funding led by AIX Ventures with backing from Sancus Ventures, Alumni Ventures, and Dent Capital. The round gives the Boston-based startup fresh capital to expand its compliance platform built specifically for healthcare AI.

The pitch: cut compliance costs in half while helping hospitals, payers, and developers keep up with a growing patchwork of regulations, from HIPAA and ONC HTI-1 to the EU AI Act.

With $6.5M in Funding, AI Startup ALIGNMT AI Targets Healthcare’s AI Compliance Gap

Hospitals have been quick to experiment with AI to improve patient care, but oversight hasn’t kept pace. Governing bodies now expect continuous monitoring, audit-ready documentation, and zero-trust safeguards. Without the infrastructure to keep up, organizations risk more than fines—they risk patient safety and public trust.

ALIGNMT AI is stepping into that gap with a governance-first platform. Instead of relying on fragmented manual processes, the system continuously tracks AI performance, flags risks in real time, and automates reporting without exposing sensitive patient data. By bringing all of those compliance checks into one place, the startup says it helps healthcare leaders move from reactive fixes to proactive oversight.

What the Funding Means

“Healthcare leaders are recognizing that AI governance is no longer optional, it’s critical infrastructure that must layer seamlessly onto existing production workflows to enable real-time risk monitoring,” said Andreea Bodnari, CEO of ALIGNMT AI. “This funding allows us to accelerate our platform development and expand our partnerships with leading healthcare institutions.”

Bodnari brings deep technical and industry experience to the challenge. An MIT-trained scientist with a PhD in machine learning, she is a serial entrepreneur and former product executive at Google and UnitedHealth Group, where she launched award-winning AI platforms. At Google, she built and scaled the B2B Healthcare AI product division. She has also spent more than a decade as a reviewer for JAMIA and is an active member of the Coalition for Health AI and the NIST AI Safety Consortium.

The company is already working with major health systems, payers, and health IT firms. It’s also the subject of a forthcoming Harvard Business School case study, set for release this winter, which highlights the growing importance of AI assurance in clinical settings.

For lead investor Krish Ramadurai of AIX Ventures, the draw is in how ALIGNMT AI gives compliance and clinical teams visibility into every AI system they’re using. “It gives clinical and compliance teams real-time visibility into every AI tool they deploy, surfacing issues instantly and helping them avoid costly mistakes. We’re already seeing healthcare providers cut compliance prep time by half, enabling them to confidently roll out new AI solutions that improve patient care safely and effectively,” he said.

What’s Next

With the new funding, ALIGNMT AI plans to grow its engineering team, build out new product features, and expand its partnerships across the healthcare industry. For hospitals and health systems eager to adopt AI but wary of the risks, the startup is betting that governance is the missing piece needed to move faster without losing trust.